Tri-Supply
Tri-supply is a joint venture company set up by Gilead Sciences Ltd and Lawrence Laboratories. The company was incorporated in January 2007.
It was set up to produce Atripla which is a combination of Sustiva, manufactured by Lawrence Laboratories and Truvada, manufactured by Gilead Sciences Limited. Atripla is the company’s only product.
It was the first once-daily single tablet regimen for HIV-1 infection intended as a stand-alone therapy or in combination with other antiretrovirals.
Financial Data
-
31st Dec 17 Source: CRO
- €72.7 million turnover
-
€37,763
profit
-
31st Dec 16 Source: CRO
- €98.3 million turnover
-
€44,242
profit
- 6 more years available »
Ranking
By Turnover
(€72.7 million)- 575th in Top Companies
- 61st in Pharma
-
- €72.7 million
Employees
- David Cadogan Director
Latest News
- 5:55am Uber’s e-bike plan for Dublin rejected on safety grounds
- 5:30am Center Parcs set to go wild at ‘subtropical’ Longford resort
- Feb 22 Carbery to extend cheese production into mozzarella
- Feb 22 UBS sticks to dividend, capital return plans after French verdict
- Feb 22 Markets optimistic over US-China trade row breakthrough hopes